FENNEC PHARMACEUTICALS INC. Operating Lease, Liability, Noncurrent
FENNEC PHARMACEUTICALS INC. (FENC) had Operating Lease, Liability, Noncurrent of $2.00 thousand as of 2023-12-31, per its 10-K filed 2024-03-29.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2024-03-29
- 2023-12-31: Operating Lease, Liability, Noncurrent $2.00K.
- 2023-09-30: Operating Lease, Liability, Noncurrent $7.00K.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2023-12-31 | $2.00K 10-K · filed 2024-03-29 |
| 2023-09-30 | $7.00K 10-Q · filed 2023-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |